SRO 552(I)/2000

GOVERNMENT OF PAKISTAN MINISTRY OF FINANCE, ECONOMIC AFFAIRS, STATISTICS AND REVENUE (REVENUE DIVISION) *** Islamabad, the 10th August, 2000. NOTIFICATION (CUSTOMS) SRO.552(I)/2000. - In exercise of the powers conferred by section 19 of the Customs Act, 1969 (IV of 1969), and in suppression of its Notification No. 373(I)/2000, dated the 17th June, 2000, the Federal Government is pleased to direct that the goods specified in Tables I, II and III below shall be exempt from so much of the customs-duty leviable under the First Schedule to the Customs Act, 1969 (IV of 1969), as is in excess of ten per cent ad valorem, if,- (a) the raw materials and packing materials, specified in Table I below, are imported by a manufacturer, approved by the Director General, Health, Government of Pakistan, under the Drugs Act, 1976 (XXXI of 1976), for manufacture of pharmaceutical products registered as drugs under the Drugs Act, 1976 (XXXI of 1976), subject to the conditions specified in that Table; (b) the raw materials and packing materials specified in Table II below, are imported for the manufacture of drugs registered under the Drugs Act, 1976 (XXXI of 1976), subject to the conditions specified in that Table; and (c ) the raw materials,specified in column (3) of Table III below, are imported for the basic manufacture of pharmaceutical active ingredients specified in column (2) thereof, subject to the conditions specified in the said Table:- Table I A. List of raw materials: DESCRIPTION (1) | PCT HEADINGS (2) Acriflavine and its salts. | 3824.9099 Activated glucronate. | 3824.9099 Acyclovir. | 3824.9099 Alkylphenoxypoly ethanol. | 3824.9099 Aluminium hydroxide, Paste/dried/gel/compressed.. | 3824.9099 Aluminium hydroxide-magnesium carbonate co-dried. | 3824.9099 Aluminium phosphate gel or dried or colloidal paste. | 3824.9099 Aluminium sucrose sulphate | 3824.9099 Amicarbional. | 3824.9099 Amidopyrinne/Aminopyrine. | 3824.9099 Amikacin sulphate. | 2941.9090 Amino acid mixture L form. | 3824.9099 Aminoglute thinmide. | 3824.9099 Ammonium salt of sulphated alkylphenoxypoly ethanol. | 3402.1290 Amoxycillin and its salts excluding Amoxycillin Trihydrate. | 3824.9099 Amphotercin-B. | 2941.9090 Amphotercin-B. | 3824.9099 Ampicillin and its salts excluding Ampicillin trihydrate and Ampicillin anhydrous. | 2941.9090 Ampicillin sodium + sulbactoum sodium pre-blended/pre-mix. | 2941.9090 Anti foam emulsion. | 3824.9099 Attapulgite. | 2508.2000 Avapyrazone sol. | 2941.9090 Azaapropazone dihydrate. | 3824.9099 Azithroneycin dihydrate | 2941.9090 Aztreonam. | 2941.9090 Baccampicillin HCL. | 2941.1020 Bacitracin and its salts. | 2941.9090 Balsam, Tolu B.P./U.S.P | 1301.9020 Beccampicillin HCL microcapsule 65-85%. | 3824.9099 Befunolol HCL. | 3824.9099 Benzilic acid dimethul octyl bromide. | 3824.9099 Betatab 75. | 3824.9099 Bezafibrate. | 3824.9099 Biological and chemical indicators. | 3824.9099 Bisacodyl. | 3824.9099 Brobenzonalidine. | 3824.9099 Brobenzoxaldine. | 3824.9099 Brotianide. | 3824.9099 Butabital. | 2941.9090 Buzepide mthiodide. | 3824.9099 Calamine. | 3824.9099 Calcium carregeenan. | 3824.9099 Captopril. | 3824.9099 Carbachol. | 3824.9099 Carbencillin and its salts. | 2941.1020 Carefcillin. | 2941.1020 Castor Oil(injection grade only). | 1515.3000 Cefaclor. | 2941.9090 Cefadroxil monohydrate. | 2941.9090 Cefaramide sterile. | 2941.9090 Cefatoxime sodium. | 2941.9090 Cefatrizine propylene glycolate. | 2941.9090 Cefazodone sodium. | 2941.9090 Cefazolin sodium. | 2941.9090 Cefazoline sodium. | 2941.9090 Cefixime. | 2941.9090 Cefizoxime sodium. | 2941.9090 Cefoperazone and its salts. | 2941.9090 Ceftazadine pentahydrate(blend). | 3824.9099 Ceftriaxone sodium. | 2941.9090 Cefuroxime. | 2941.9090 Cefuroxime axtil granules. | 2941.9090 Cefuroxime sodium. | 2941.9090 Cephalexin sodium. | 2941.9090 Cephaloridine. | 2941.9090 Cephradine. | 2941.9090 Cetomacrogol 1000(Texofor). | 3402.1990 Cetrimide. | 3808.4090 Clindamycin. | 2941.9090 Cloxacillin and its salts excluding cloxacillin (compacted/powder form for oral use). | 2941.1020 Coated granules for moriamin capsules. | 3824.9099 Colistin sulphate. | 2941.9090 Collagen strip (catgut). | 4206.1000 Concentrate of lactoserum brocein of 65% nitrogen. | 3824.9090 Cylaserine and its salts. | 2941.9090 Cytochrome-C. | 3504.0000 Decoquinate. | 2941.9090 Decoquinate 6% W/W. | 2941.9090 Dextran 40 & 70 (pharma grade). | 3913.9000 Dextrose(injectabale grade). | 1702.3000 Dimethicone/simethicone. | 3824.9099 Dioctahedral smeltite. | 3802.9000 Doxepin and its salts. | 2909.3090 Enrofloxacin. | 2941.9090 EPL substances (essential Phospholipids). | 3824.9099 Eriodictyon. | 1211.9099 Erodictyon. | 1211.9099 Exracepae. | 3824.9099 Extract absinthii. | 1302.1990 Extract Aconite. | 1302.1990 Extract belladonna liq or sicc. | 1302.1990 Extract benzoin. | 1302.1990 Extract buchu. | 1302.1990 Extract capsicum. | 1302.1990 Extract colae siccum. | 1302.1990 Extract colchicine . | 1302.1990 Extract coltsfoot. | 1302.1990 Extract ginkgo biloba. | 1302.1990 Extract glyoyrrhiza (liquid/siccum). | 1302.1990 Extract hyoscyamous. | 1302.1990 Extract ipecac. | 1302.1990 Extract krameira. | 1302.1990 Extract liriosma ovate. | 1302.1990 Extract lobelia. | 1302.1990 Extract myrrh. | 1302.1990 Extract nuxvomica. | 1302.1990 Extract pine bark. | 1302.1990 Extract quassia +. | 1302.1990 Extract rhei. | 1302.1990 Extract scillae. | 1302.1990 Extract stramonium. | 1302.1990 Extract strychnos. | 1302.1990 Extract thyme. | 1302.1990 Extract valerian. | 1302.1990 Extract witch hazel. | 1302.1990 Extraxct senega. | 1302.1990 Eyeless sucures needles. | 7319.9000 Flucloxacillin sodium. | 2941.1020 Fosfomycin and its salts. | 2941.9090 Framycetin sulphate. | 2941.9090 Fusidic acid anhydrous. | 2941.9090 Fusidic acid hemihydrate. | 2941.9090 Gelatin. | 3503.0000 Gentain roots/extracts. | 1302.3900 Gentamicin and its salts. | 2941.9090 Gentian violet. | 3204.1300 Gentian/ Pluv Gential. | 3204.1300 Ginkgo Biloba Extract. | 1302.1990 Glassine sleeve. | 4819.5000 Gluethimide. | 3824.9099 Glyceryl mono stearate, distearate and mono ricinoleate. | 3404.9090 Gramicidin. | 2941.9090 Gramicidin. | 2941.9090 Gumbenzoin, Styrax, Trageacanth, Xanthan. | 1301.9090 Hemicellulose. | 1302.3900 Hyoscyamus leaves. | 1211.9091 Imidapril HCL. | 3824.9099 Intrinsic factor. | 3824.9099 Ipecac. | 3824.9099 Iron-dextran or sorbitol- citric acid complex. | 3824.9099 Ispaghule husk(B.P) chlorzoxazone. | 1404.9090 Kanamycin sulphate. | 2941.9090 Levofloxacin. | 2941.9090 Lincomycin and its salts. | 2941.9090 Loratadine. | 3824.9099 Losartan potassium. | 3824.9099 Lovastatin. | 3824.9099 Lyophlised saccharomyces boulardii. | 3824.9099 Macloxamine dihydrogen citrate. | 3824.9099 Magaldrate gel sulphate. | 3824.9099 Magaldrate powder USP. | 3824.9099 Magnesium probencid. | 3824.9099 Marvelon. | 3824.9099 Medicamycin acetate fine granules. | 3824.9099 Methisoprinol. | 3824.9099 Midecamycin acetate (fine granules/powder). | 2941.9090 Midodrine hydrochloride. | 3824.9099 Mometasone fursate. | 3824.9099 Momochloracarvacrol. | 3824.9099 Monensin. | 2941.9090 Mozantel tartazate. | 3824.9099 Mucoproteose. | 1302.3900 Mucpirocin. | 2941.9090 Myrrh. | 1301.9090 Neomycin and its salts. | 2941.9090 Novobiocin, its derivatives and salts. | 2941.9090 Nystatin. | 2941.9090 O-(2 hydroxyethyl) amylopectin hydrolysate Polly (O-2 hydroxyethyl) starch. | 3504.0000 Ofeandomycin, its derivatives and salts. | 2941.9090 Opalux, Opadry, Opaspray, Opglos. | 3824.9099 Ossein mineral complex. | 3505.0000 Polymyxine (polymyxin-b-sulphate ). | 2941.9090 Polyoxethylene oleic triglycerides. | 3907.2000 Polyoxethylene-polymer. | 3907.2000 Polyvinylpyrrilidone (pharmaceutical grade). | 3905.9900 Polyvinylpyrrilidone iodine. | 3905.9900 Pregelled/ pregelatinized starch. | 3505.1000 Pre-mixed powder of sulbactum sodium and amoxycillin sodium in the ratios 250 mg, 500mg for sulbamox 750 inj., 500 mg, 1000mg for subamox DS inj. | 2941.9090 Protamine sulphate. | 3504.0000 Prune virginian. | 1211.9099 Raubasine.. | 3824.9099 Rice hulls. | 1104.2900 Rhubarb leaves/roots. | 1404.9090 Rifampicin. | 2941.9090 Rifater pre-mix. | 3824.9099 Risperidone. | 3824.9099 Roxatidine acetate HCL. | 3824.9099 Roxithromycin. | 2941.9090 Rufloxacine. | 2941.9090 Ruscogenine. | 3824.9099 Secrosteron. | 3824.9099 Selenium sulfide with bentonite. | 3824.9099 Senega. | 3824.9099 Senidazole. | 3824.9099 Septocemobin. | 3824.9099 Seuzm. | 3824.9099 Silymarine. | 3824.9099 Simvastatin. | 3824.9099 Sodium chloride (injectable grade). | 2501.0090 Sodium fusidate. | 2941.9090 Sodium lodohepartinate. | 3824.9099 Sodium parrolodone crboxylate. | 3824.9099 Sodium succinate 6H20. | 3824.9099 Spfeen powder. | 3824.9099 Spironolactone. | 3824.9099 Spraydried sodium polyhydoxyaluminium. | 3824.9099 Streptohyrazine. | 2941.9099 Sultamicillia tosylate. | 2941.1020 Sultamicillin. | 2941.1020 Surfen. | 3824.9099 Tergitol. | 3824.9099 Tetanus toxoide. | 3824.9099 Thiamulin hydrogen fumarate. | 2941.9090 Tibolone. | 3824.9099 Tincture asafoetide. | 1302.1910 Tincture bronchicum. | 1302.1910 Tincture capsicum. | 1302.1910 Tincture gimdcifugee. | 1302.1910 Tincture gimdcifugee. | 1302.1910 Tincture myrrh. | 1302.1910 Tincture oucbracho. | 1302.1910 Tincture primula. | 1302.1910 Tincture strychors. | 1302.1910 Tincture thyme. | 1302.1910 Tobcoat TC. | 3824.9099 Tobramycin. | 2941.9090 Tribulus terrestris. | 3824.9099 Triple antigen concentrate. | 3824.9099 Trothricin. | 2941.9090 Tylosin and its salts. | 2941.9090 Valerine roots. | 1404.9090 Vancornycin HCL. | 2941.9090 Viomycin sulfate. | 2941.9090 Virginiamycine. | 3824.9099 Zinc bacitrain zinc monomethionine complex. | 3824.9099 B. List of packing materials. 1. Ampoule cutter. 2. Aerosol therapy apparatus and its components. 3. Aluminum foil printed, indicating particulars of drug and manufacturer, in roll for strip/blister packing of tablets/capsules. 4. Canaleur and its caps for infusion sets. 5. Edible ink. 6. Empty glass infusion bottle with and without graduation USP II. 7. Metallic twisters for flow regulators. 8. Plastic nebuliser/dropper bottles for ear, eye and nasal drops with or without assembly. 9. Plastic nebuliser. 10. Stoppers for I.V. solutions. 11. Neutral glass cartridges with rubber dices and pungers and aluminium seals. 12. Plastic eye baths. 13. Printed aluminium foil for sachet/I.V. infusion bag. 14. Printed viskerings. 15. Tear off aluminium seals for injectables. 16. Non-toxic plastic bags for I.V. solutions of dextrose and other infusions. 17. Filp off seals for injectable vials. Conditions:- (i) The importer, shall make at the time of clearance from Customs, a declaration on the bill of entry that the goods will not be used for any purpose other than the manufacture of pharmaceutical products registered as drugs under the Drugs Act, 1976 (XXXI of 1976); and (ii) The importer-cum-manufacturer shall maintain record of the goods imported and the pharmaceutical products manufactured therefrom and shall produce the same whenever so required by the appropriate officer of customs or the Director-General, Health, or an officer authorized by him in that behalf: Provided that the exemption in excess of ten per cent ad val., granted by this notification shall not apply to the import of raw materials and packing materials for the purpose of manufacture by way of repackaging of drugs: Provided further that the availability of the aforementioned facility will be restricted to drugs manufacturers for such raw materials which have duly been registered and approved by the Director-General, Health, in accordance with the provisions of the Drugs Act, 1976 (XXXI of 1976). The said facility shall take effect from the date of the registration of the drug under the Drugs Act, 1976, as per registration certificate issued by the Ministry of Health to the pharmaceutical manufacturers using any one or more of the pharmaceutical raw materials mentioned above. Table II A. List of raw materials: DESCRIPTION | P.C.T HEADINGS Acesulfame potassium acetanilide. | 3824.9099 Acid undecenoic B.P. | 3824.9099 Alkyl aryl sulfonate. | 3402.9099 Ampnocerin 'K' or 'KS'. | 3824.9099 Amylopectin. | 3505.1000 Anhydrous di-sodium carbonate. | 2836.3000 Animal charcoal (activated carbon). | 3802.1000 Antifoam F.D. | 3824.9099 Benzene calcium sulphonate. | 2917.3900 Bevaloid dispersant. | 2707.9900 Biotin 1% in calcium phophate. | 3824.9099 Bismuth citrate, subcarbonate, subgallate, subnitrate and subiodide. | 2504.9000 Butyl phthalate | 2917.3100 Capsicum oleoresin (caposicin). | 3301-9090 Carboxypolymethylene/caboxy vinyl polymer(carbopol/carbomer). | 3906-9090 Carbpoxymethyl cellulose and its salts. | 3912-3100 Casein formaldehyde. | 1521-9000 Catalysts. | 3815.0000 Catastay powder. | 3824.9099 Cellulose and its derivatives. | 3501-3900 Cetearyl octanoate. | 3824.9099 Cetostearyl alcohol. | 3823-7010 Cetylester wax. | 3404-9090 Chlorophyll. | 3824.9099 Coal tar distillate/solution. | 2706.0000 Collone wax. | 3404.9000 Colophony resin. | 3906.9090 Copra fatty acid diethanolamide. | 3823.7090 Cremoophor. | 3402.1310 Decelite . | 3802.9000 Diascorea roots / powder. | 1302.3900 Dibutylphthalate. | 2917.3100 Diffutabe base E2. | 3824.9099 Dodecylbenzensulphonic acid salts. | 3402.1110 Emulsional. | 3823.7090 Endracite - E. | 3824.9099 Essences in powder for use in ors(lemon,lime, orange,pineapple,cherry only). | 2106.9019 Essential oils (anisi, cinnamon, caraway, cardamom, nutmeg,lemon,peppermint only). | 3301.9010 Ethanol. | 2207.1000 Ethyl acetate. | 2915-3100 Ethyl oleate. | 3824.9099 Eucalyptus oil, eucalyptol. | 3301-9010 Eucerin. | 3824.9099 Eudragit all kinds. | 3824.9099 Explotab. | 3824.9099 Extract bitter orange peels. | 2101-2090 Extract wild cherry. | 2101-2090 Ferric oxide phosphate and pyrophosphate. | 3824.9099 Food colour (pharmaceutical grade). | 3205-0000 Glycofurol. | 3824.9099 Gum acacia powder BP. | 1301-9090 Gum benjamin BP. | 1301-2000 Hard fat. | 1501-0090 Hydorxy propyl methyl cellulose. | 3912-3100 Hydrogenated methyl abietate. | 3806-9000 Hydrogenated oil. | 1515-1900 Igepon AC-78 and TC-42. | 3402.1110 Infusorial earth(Kieselguhr/Hyflo-supercel/celite). | 2512.0000 Instant rice. | Respective heading Lactose. | 1702-1000 Lanette wax. | 2712-9000 Lanolin (wool alcohol / fat). | 1505.9000 Laponite SLG. | 1505-9000 Laury dimethyl aminoxide. | 3823.7090 Lemon pippermint only. | 3301.9090 Lemon, lime and orange essences(in powder). | 2106.9019 Linseed oil. | 1515.1900 Lucryl amidoletaine. | 3824.9099 Lunacera M. | 3823-7090 Macrogol lauryl ether. | 3907-2000 Malt extract. | 1901-9010 Maltadextrin. | 1702.9040 Megyol -W mixture. | 1516.2090 Methyl methacrylate copolymer(mana copolymer). | 3906.1000 Methylene blue. | 3824.9099 Methyvinyl ether maleic anhydride copolymer. | 3906.9090 Microcrystalline cellulose its derivatives and salts. | 3912.3900 Microcrystalline waxes. | 3404.9090 Migloyl -812. | 1516.2090 Monofilament stainless steel/ Nylon/Polypropylene WP/BPC/USP. | Respective heading -do- Orthotolunen Sulfonamide OTSA. | 2935.0010 Palm kernel Oil PEG-6 Complex. | 1513.2110 Paraffin hard. | 2712.9000 PEG-75 Stearate and Glyceryl Stearate. | 3404.2000 Persnganate, Sulphate, Succinate. | 3824.9099 Peuronic L-62. | 3824.9099 Pharmacoat. | 3912.3900 Plaited (braided) polyester coated BPC/USP. | Respective heading -do- Plaited (braided) silk USP/BPC. | -do- Plastibase. | 2710.0099 Polyethylene glycol and its derivatives. | 3404.2000 Polygel. | 3824.9099 Polyglyceryl ricinoleates. | 3907.9900 Polymerized acrylic acid. | 3824.9099 Polyoxyethylene. Glycol/Glycerides/Polyoxyl stearate. | 3404.2000 Polyoxyl stearate. | 3824.7090 Potassium on charcol 5% catalyst. | 3815.9000 Prepared Storax. | 3824.9099 Primojel. | 3505.1000 Promulgen. | 3824.9099 Propandeiol mona distearate. | 3824.9090 Propl gallate . | 3824.9099 Quassin solution. | 3824.9099 Quinaldine and its salts. | 3824.9099 Rhizome galangae. | 1211.9099 Rhodigel ( food grade). | 3824.9099 Sandarac. | 3824.9099 Sesame oil ( for injection). | 3301.2190 Silicon emulsion. | 3910.0000 Sodium carraghenate. | 3505.1000 Sodium croscarmellose. | 3912.3100 Sodium formaldehyde hydrogen sulphide. | 3824.9099 Sodium lauryl alcohol/sulphate. | 3402.1990 Sodium linear alkylatesultonate. | 3824.9099 Sorbhilan and its derivatives(tweens and spans). | 3402.1310 Sorbitol crystalline powder. | 2905-4400 Spermacetic. | 1521.9000 Sterilisable maize starch. | 1108.1200 Talc (pharmaceutical grade ). | 2526.2000 Tenox-2. | 3824.9099 Texapon E- 13. | 3402.1910 Texapon K- 12. | 3402.1910 Vinylpyrrolidinone vinyalaectate Copolymer. | 3905.9900 Viscarin. | 3824.9099 Wax emulsifying witepsol. | 3404.9090 Witepsol. | 3404.9090 B. List of packing materials. 1. Aluminium foil printed, indicating particulars of drug and manufacturer in roll for wrapping. 2. Un-printed aluminium foil with coating of Mylar Polyester adhesive or Surlyn Iononer resin on one side and vinyl coating on the other side. 3. Polyester polyethylene film of polyester (Melinerxor Mylar) and low density poly-ethylene. 4. Medical bleached kraft paper metalized on the smooth side and coated on the rough side with heat seal coating lacquer. 5. Medical kraft paper with heat seal coating of EVA resin base; White tag board of bleached wood pulp. 6. Neutral Glass Vials 1-2 ml U.S.P-1. 7. Moulded Glass Vials U.S.P. Type III (for antibiotics Inj-powder). 8. Printed Cellophane Viscose packing and wrapping Flim. 9. Printed Poly Bags for infusion sets. 10. 13 mm Rubber stoppers for injections. 11. 20 mm and 32 mm Rubber stopper for injections. 12. Soft non-toxic PVC Film/lay flat tube for medical application. 13. PVC non-toxic tubing for medical application. 14. Preformed printed pet Slvees. 15. Glass bottle USP type I. 16. Pre-printed Polypropylene tubes with tamper proof closures (with or without dessicant) indicating particulars of registered drug and manufacturer. 17. Bottle pack caps FK-28 including a rubber disc and a compound ring for Haemaccel, Sterilized. 18. Lupolen 1840H Q211 for molding haemaccel bottles. 19. Neutral, clear glass, USP type I (presterilized) close mouth, glass ampoules with long straight stem. Conditions:- (1) The manufacturer shall furnish to the Health Division the quantities of the raw/packing materials along with the details of the drugs to be manufactured therefrom, and the Director General Health or any other officer authorized in this behalf will certify for each consignment requirements of raw/packing materials along with the names of the drugs to be manufactured therefrom in the Form-I set out below. (2) At the time of import of raw/packing materials, the manufacturer shall make a written declaration on each copy of the bill of entry to the effect that the raw/packing materials have been imported in accordance with his entitlement in terms of condition (1). (3) The Collector of Customs shall allow release of the raw materials against bank guarantee or indemnity bond along with post-dated cheque equivalent to the amount of customs-duty exempted under this notification. (4) The manufacturer shall maintain records of the materials imported and drugs manufactured therefrom, and shall produce the same whenever so required by the appropriate officer of customs or the Health Division. (5) The manufacturer shall within fifteen months of the date of filing of bill of entry for home consumption relating to the raw/packing materials, apply to the Collector of Customs for discharging the bank guarantee or insurance guarantee, the application being supported by a certificate in the Form-II set out below, issued by the Director General Health or any other officer authorized in this behlaf. (6) The concession shall take effect from the date of the registration of the drug under the Drugs Act, 1976, as per registration certificate issued by the Ministry of Health to the pharmaceutical manufacturers using any one or more of the pharmaceutical raw materials specified in this notification. Table III. S.No. | Products to be manufactured | List of raw materials (1) (2) (3) --------------------------------------------------------------------------------------------------------------- (I) (a) Caphalexin Hydrate;and 1. Celite J-2. (b) Caphradine Hydrate. 2. Charcoal Darko KB. 3. Ethyl Acetate. (II) (a) Betamethasone; and 1. Norit CN3. (b) Clobetasol 17-Proprinate. 2. Clarcel flo(Celite). 3. Ethyl Acetate. 4. Methane sulphonyl chloride. 5. Sodium dichromate. 6. Sodium Sulphate Anhydrous. 7. Yeast Extract Powder(Oxoid/Difco). (III) Salbutamol. 1. Charcoal CN3. 2. Ethyl Acetate. 3. Hyflo Supercel. 4. N-Propanol. 5. Sodium Hydroxide B.P. (IV) Ranitidine Hydrocloride. 1. Celite J-2. 2. Charcoal CN3. 3. Dimethylamine Hydrochloride. 4. Hyflo Supercel. (V) Trichloroethyl Phosphate. 1. Sodium Mehtoxide. (VI) Trimethoprim(pure). 1. Sodium Mehtoxide. 2. Charcoal Powder(Activated Carbon). (VII) Griseofulvin. 1. Antifoam CLRS: Oil.Substitute. 2. Charcoal Powder SX Plus. 3. Clarcel Flo CR 4. Soya Bean Oil Degummed. (VIII) Dexamethasone Sodium Phosphate. 1. Sodium Hydroxide. (IX) Cephalexin. 1. Demulsifier. 2. N-Butyl Acetate. (X) Glibenclamide. 1. Cyclohexyl isocynate. 2. Norit supra A. 3. Sodium hydroxide flakes. (XI) Pheniramine maleate. 1. Dicalite 4258. 2. Maleic Acid. 3. Norit. 4. Acetone. (XII) Frusemide. 1. Lasamide. 2. Norit SX2. 3. Trilon B. (XIII) Cephalexin and cephradine. 1. Crude penicillin ‘G’. (XIV) Ampicillin Trihydrate. 1. Concentrated (Tech Hydrochloric Acid Grade) 2. Concentrated Ammonium Hydroxide -do- 3. Ethylacetoacetate -do- 4. 2-Ethylhexanoic acid -do- (XV) Amoxycillin Trihydrate. 1. D-(-)-P-Hydrexy- -do- phenylglycine 2. Concentrated Hydrochloric acid -do- 3. Concentrated Ammonium Hydroxide -do- (XVI) Cloxacillin sodium 1. Ethyl Acetate. 2. 2-Ethyl Hexanoate Acid. (XVII) Doclofenac. 1. Cuprous Oxide. 2. Cuprous iodide. 3. T-Butyl methyl ether. 4. Charcoal CN3 . 5. Methylene chloride. (XVIII) Glibenclamide. 1. Dicalite 4258; and (XXIX) Frusemide. 1. Dicalite 4258. (XX) Polygeline.(This is subsequently used for 1. Gelatine No.17471 Acetone. The formulation of finished drug ‘Haemaccel). 2. Clacium Chloride, Sodium Hydroxide. 3. Hydrochloride Acid,Hexa. Methylene Di-isocynate. (XXI) Betamethasone. 1. Acetone. (XXII) Cephalexin Hydrate/Cephradine Hydrate. -do- (XXIII) Griseofulvin. -do- (XXIV) Triclofos. -do- (XXV) Betamethasone/Clobetasol 17-Propionate. 1. 16-DPA. (XXVI) Salicylic Acid. 1. Sodium Hydroxide. (XXVII) Aspirin. 1. Sodium Hydroxide. (XXVIII) Methyl Salicylate. 1. Sodium Carbonate. (XXIX) Sodium Salicylate. 1. Activated Carbon. (XXX) Paracetamol/Para aminophenol. 1. Sodium Nitrite. (XXXI) Ampicillin Anhydrous. 1. 2-Ethyl Hexanoic Acid. (XXXII) Alprazolam U.S.P. 1. ALP-Chloride. (Methanone,(5,chlore-2-2 (3(Chloromethyl)-5- Methyl-4H-1, 2,4-Triazol-4yl) Phenyl) Phenyl. 2. Ethyl Acetate) Technical Grade Undenatured) 3. Ammonium Hydroxide Solution (Technical Grade 29% NH3). 4. Acetone Extra Pure B.P.N.F.EUP. (XXXIII) Sulphamethoxazole. 1. Carbon. 2. Isoxamine, (3 Methyl 5 Amino Isozazole) (XXXIV) Ibuprofen. 1. Sodium Dichoromate. 2. Acetone. 3. Carbon. (XXXV) Ciprofloxacin. 1. Carbon. (XXXVI) Norfloxacin. 1. 3 Chloro 4-Fluoro Aniline. 2. EMME(Diethyl Ethoxy Methylene Malonate) 3. Parafin. 4. Acetone. 5. Diethyl sulphate. 6. Carbon. 7. Supercel. (XXXVII) Pefloxacin. 1. Carbon. (XXXVIII) Pencillin Crude. 1. Corn Steep Liquor. (Phenylacetamide pencillanic Acid Potassium salts) 2. Gemex. 3. Filter Pads. 4. Prod + Floc. 5. Nadar Cento. 6. Linqquad. 7. Liquid Glucose(Dextrose). 8. Stearic Acid. 9. Pharmamedia. 10. N.Butyl Acetate. 11. Acetone. 12. Celite. 13. Activated Carbon. 14. Formaline. (XXXIX) Pencillin, its derivatives and slats. 1. Carboxy Methyle Cellulose. Sodium. 2. Filter Pads. 3. N-Butyl Acetate. 4. Acetone. 5. Celite. 6. Activated Carbon. 7. Carbonate. 8. Potassium Carbonate. 9. Sulphuric Acid. (XL) Magnesium Hydroxide. 1. Magnesium Oxide. (XLI) Spironolactone. 1. Aldona (17-Hydroxy-3- OXO-17-a- Pregna-4-ene; 17 B Carbolactone). 2. Dimethyl formamide. 3. Acetone. 4. Hyflosupered(Diatomeceous Earth). 5. Aldadiene(17-Hydroxy-3-OXO-17-a- _regna-4,6-diene-21-Carboxylic Acid Y-Lactone). 6. Activated Carbon Norit CN3. (XLII) Haloperidol. 1. Acetone. 2. Hyflosupercel(Diatomaceous Earth). (XLIII) Ephedrine. 1. Acetone. 2. Filter Aid. 3. Platinum Catalyst. (XLIV) Santonin . 1. Activated Charcoals. (XLV) Cephradine. 1. N.N-Dimethyl Acetamide (DMA).. 2. Cephalosporanic Acid (7-ADCA). 3. Acetone. 4. Activated Carbon. (XLVI) Cephalexin Hydrate. 1. D (-) Alpha Phenyl Glycine. 2. N.N-Dimethyl Acetamide(DMA). 3. Diethylamine. 4. 7-ADCA. (XLVII) Penciallin salts. 1. Crude Pencillin. (XLVIII) Ciprofloxacin Hel. 1. Activated Carbon. (XLIX) Norfloxacine. 1. Activated carbon. 2. Acetone. (L) Peefloxacin. 1. Formic acid. 2. Methane. (LI) Betamethasone products. 1. Triene (21-Acetoxy-17- Hydroxy-16-Beta- Methyl-Pregna-1, 49,(II)-Triene-3, 20 Dione. (LII) Cephradine. 1. Ethylenediaminetetra-acetic acid sodium salts(EDTA-NA). 2. Activated Carbon(Animal Porous). 3. Diatomite(Filter aid). Conditions:- (1) The manufacturer shall furnish to the Ministry of Health or any other officer authorized by the Ministry of Health in this behalf in the prescribed Form, the details of the raw materials required for manufacturing pharmaceutical active ingredients who will get the unit surveyed by an inspection team constituted by the Ministry of Health and consisting also a member nominated by the Central Board of Revenue shall certify the annual capacity of the unit for the manufacture of basic drugs and the total annual requirements of various types of raw materials along with the quantities required for the basic drugs. (2) The manufacturer shall furnish to the Health Authorities concerned the quantities of the raw materials imported along with the details of the products or basic drugs manufactured therefrom and the Director General of Health, Government of Pakistan, or any other officer authorized by him in this behalf shall certify for each consignment the requirements of raw materials along with the names of the products to be manufactured therefrom in Form-I set out below. (3) At the time of import of the raw materials the manufacturer shall submit a declaration in writing on each copy of the bill of entry to the effect that the raw materials have been imported in accordance with his entitlement in terms of condition (1). (4) The Collector of Customs shall allow release of the raw materials against a bank guarantee or indemnity bond along with post-dated cheque equivalent to the amount of customs-duty exempted under this notification. (5) The manufacturer shall maintain record of such materials imported and the end products manufactured therefrom, and shall produce the same on demand by the appropriate officer of Customs or the Health Authorities. (6) The manufacturer shall, within fifteen months of the date of filing of bill of entry for home-consumption relating to the raw materials, apply to the Collector of Customs for discharging the bank guarantee or indemnity bond and post-dated cheque. Such application shall be supported by a certificate in Form-II set out below, issued by the Director General Health, Government of Pakistan, or by any other officer authorized by him in this behalf to the effect that the basic drug for which the raw materials were imported has been made out of those materials. (7) The Bank Guarantee or the Indemnity Bond along with post-dated cheque, as the case may be, shall be discharged by the Collector of Customs on receipt of application from the partyduly accompanied by a certificate from the Director General of Health, Government of Pakistan, or by any other officer authorized by him in this behalf, as required in terms of condition (5). FORM-I I (Name) ……………………………… Directorate General of Health, Government of Pakistan, duly authorized in this behalf by the Director General of Health, Government of Pakistan, do hereby certify that the raw/packing materials mentioned in the Schedule below have been imported for the manufacture of pharmaceutical active ingredients, products, drugs, i.e., ……………………………… (Name of product) under bill of Lading No. ……………dated …………………IGM No… dated ……………………… Index No………………….. Name of the importer-cum-manufacturer and the quantity to be manufactured. | Name and quantity of the raw/packing materials imported for the manufacture. Signature_______________. Designation.________________. FORM-II I (Name) ...........................Directorate General of Health, Government of Pakistan duly authorized in this behalf by the Director General of Health, Government of Pakistan, do hereby certify that the raw/packing materials imported by (………………….............) for the manufacture of pharmaceutical (Name of the importer) active ingredients/products/drugs i.e. ......................under bill of entry No...........dated....……….., IGM No.............. dated.......………Index No........ ................) according to the details given below have been used for the manufacture/packing of ______________ in accordance with the scale laid down by (Name of drug) In case of multiple drugs, add sheet the Health Division vide certificate No. ________________ dated ______. Name of the importer- cum -manufacturer and the quantity to be manufactured. | Name and quantity of the raw/packing material imported for the manufacture. Signature_________________. Designation________________. 2. This notification shall be deemed to have taken effect from the 17th June, 2000. [C.No. 6(4)/2000-CB r/w 36-S (CB)/2000] (MIR FUAD) Additional Secretary Appendix V-Concessions to Privileged Persons and Organisations. S.No. Page 1. Act No. XX of 1948 relating to United United Nations (Privileges and Immunities) Act 1948. 773 Nations Privileges and Immunities. 2. C.B.R’s C.No 8(61)-Cus-I/51.- Rules regarding import and sale of cars by diplomats. 777 dated 1-11-1958 3. C.B.R’s C.No. 8(61)Cus-I/51.- Rules regarding sale of goods by diplomats and other dated 13-5-1960 privileged persons and organisation. 777 4. C.B.R.’s C.No. 10(34)-Cus.III/58.- Model Rules for Customs concessions to privileged personnel dated 18.4.1963 arriving under various foreign aid programmes or projects. 778 5. S.R.O. 53(I)/70.-dated 16-3-1970 Goods imported by Rulers of Gulf Sheikhdoms for personal use. 779 6. Act No. IX of 1972, relating to Vienna Diplomatic and Consular Privileges Act, 1972. 780 Convention.- dated 12-9-1972 7. Act No LVIII of 1975 relating to The President’s Salary, Allowances and Privileges Act, 1975. 793 privileges of the President.-dated 28-7-1975 8. Act No. LIX of 1975 relating to The Prime Minister’s Salary, Allowances and Privileges privileges of the Prime Minister.- Act, 1975 796 dated 28-7-1975 9. President’s Order No. 5 of 1975.- The Gover’s Salary, Allowances and Privileges Order, dated 9-7-1975 1975. 799 10. President’s Order No. 19 of 1978.- The Acting Governors (Allowances and Privileges) dated 17-10-1978. Order, 1978. 804 11. S.R.O. 1148(I)/82. - dated 21-11-1982 Goods imported by organisations in Pakistan from the church World Service or the Catholic Services. 804 ACT NO XX OF 1948 Relating to the United Nations Privileges and Immunities. (Passed by the Pakistan Constituent Assembly (Legislature) (Received the assent of the Governor-General on the 16 June, 1948). An Act to give effect to the Convention on the Privileges and Immunities of the United Nations. WHEREAS it is expendient to give effect to the Convention on the Privileges and Immunities of the United Nations, and to enable similar privileges and immunities to be enjoyed by the other international organizations and their representatives and officials; It is hereby enacted as follows:- (1) This Act may be called the United Nations (Privileges and Immunities) Act 1948. (2) (1) Notwithstanding anything to the contrary contained in any other law, the provisions set out in the Schedule to this Act of the Convention on the Privileges and Immunities, adopted by the General Assembly of the United Nations on the 13th day of February, 1946, shall have the force of law in Pakistan. (2) The Central Government may, from time to time, by notification in the Official Gazette amend in the Schedul conformity with any amendnents, duly made and adopted, of the provisions of the said Convention set out therin. (3) Where in pursuance of any international agreement, convention or other instrument it is necessary to accord to any international organization and its representatives and officers privileges and immunities in Pakistan similar to those contained in the provision set out in the Schedule, the Central Government may, by notification in the official Gazette, declare that the provisions set out in the Schedule shall, subject to such modifications, if any, as it may consider necessary or expedient for giving effect to the said agreement, convention or other instrument apply mutatis mutandis to the international organization specified in the notification and its epresentatives and officers, and thereupon the said provision shall apply accordingly and notwithstanding anything to the contrary contained in any other law, shall in such application have the force of law in Pakistan. (4) The Central Government may make rules for carrying out the purposes of this act. THE SCHEDULE (see section 2&3) ARTICLE I Judicial Personality Section1.- The United Nations possess shall judicial personality. It shall have the capacity:- (a) to contract; (b) to acquire and dispose of immovable and movable property; (c) to institute legal proceedings. ARTICLE II PRORERTY, FUNDS AND ASSETS Section2.- The United Nations, its property and assets wherever located and by whomsoever held, shall enjoy immunity from every form of legal process except in so far as in particular case it has expressly waived its immunity. It is however, understood that no waiver of immunity shall extend to any measure of execution. Section3.- The primises of the United Nations shall be inviolable. The property and assets of the United Nations, wherever located and by whomsoever held, shall be immune From search, requistion, confiscation, expropriation and any other form of interference, whether by executive, administrative, judicial or legislative action. Section4.- The archives of the United Nations, and in general all documents belonging to it or held by it, shall be inviolable wherever located. Section5.- Without being restricted by financial controls, regulations or moratoria of any kinds. (a) The United Nations may hold funds, gold or currency of any kind and operate accounts in any currency; (b) The United Nations shall be free to transfer its funds, gold or currency from one country to another or within any country and to convert any currency held by it into any other currency. Section 6.- In exercising its right under Section 5 above, the United Nations shall pay due regard to any representation made by Government of any member in so far as it is considered that effect can be given to such representations without detriment to the interest of the United Nations. Section 7.- The United Nations, its assets, income and other property shall be:- (a) exempt from all direct taxes; it is understood, however, that the United Nations will not claim exemption from taxes which are, in fact no more than charges for public utility service. (b) exempt from customs duties and prohibitions and restrictions on imports and exports in respect of articles imported or exported by the United Nations for its official use. It is understood, however, that articles imported under such exemption will not be sold in the country into which they were imported except under conditions agreed with the Government of that country; (c) exempt from customs duties prohibitions and restrictions on imports and exports in respect of its publications. Section 8.- While the United Nations will not, as a general rule, claim exemption from excise duties and from taxes on the sale of movable and immovable property which forms part of the price to be paid, nevertheless when the United Nations is making important purchases for official use of property on of which such duties and taxes have been charged or are chargeable. Members will, whenever possible, make appropriate administrative arrangements for the remission or return of the amount of duty or tax. ARTICLE III FACILITIES IN RESPECT OF COMMUNICATIONS Section 9.- The United Nations shall enjoy in the territory of each Member for its official communications treatment not less favourable than that accorded by the Government of that Member to any other Government including its diplomatic mission in the matter of priorities, rates and taxes on mails, cables, telegrams, radiogrammes, telephone, telephotos and other communications; and press rates for information to the press and radio. No censorship shall be applied to the official correspondence and other official communications of the United Nations. Section 10.- The United Nations shall have the right to use codes and to despatch and receive its correspondence by courier or in bags, which shall have the same immunities and privileges as diplomatic couriers and bags. ARTICLE IV THE REPRESENTATIVE OF MEMBERS Section 11.- Representatives of Members to the Principal and subsidiary organs of the United Nations and to conferences convened by United Nations, shall while exercising their functions and during their journey to and from the place of meeting, enjoy the following privilges and immunities:- (a) immunity from Personal arrest or detention and from the seizure of their personal baggage, and, in respect of words spoken or written and all acts done by them in their capacity as respresentatives, immunity from legal process of every kind; (b) inviolability for all papers and documents; (c) the right to use codes and to receive papers or correspondence by courier or in sealed bags; (d) exemption in respect of themselves and their spouses from immigration restrictions aliens registration or national service obligations in the state they are visiting or through which they are passing in the exercise of their functions; (e) the same facilities in respect of currency or exchange restrictions as are accorded to representatives of foregin governments on temporary official missions; (f) the same immunities and facilities in respect of their personal baggage as are accorded to diplomatic envoys, and also (g) such other privileges, immunities and facilities not inconsistent with the foregoings as diplomatic envoys enjoy, except that they shall, have no right to claim exemption from customs duties on goods imported (otherwise than as part of their personal baggeg) or from excise duties or sales taxes. Section 12.- In order to secure, for the representatives of Members to the principal and subsidiary organs of the United Nations and to conferences convened by the United Nations, complete freedom of speech and independence in the discharge of their duties, the immunity from legal process in respect of words spoken or written and all acts done by them in discharging their duties shall continue to be accorded, notwithsatanding that the persons concerned are no longer the representatives of Members. Section 13.- Where the incidence of any form of taxation depends upon residence, periods during which the representatives of Members to the principal and subsidiary organs of the United Nations and to conferences convened by the United Nations are present in a state for the discharge of their duties shall not be considered as period of residence. Section 14.- Privileges and immunities are accorded to the representatives of Members not for the personal benefit of the individuals themselves, but in order to safeguard the independent exercise of their functions in connection with the United Nations. Consequently a Member the immunity would impede the course fo justices, and it can be waived without prejudice to the purpose for which the immunity is accorded. Section 15.- The provisions of Section 11, 12 and 13 are not applicable as between a repesentative and the authorities of the state of which he is national or of which he is or has been the representative. Section 16.- In this article the expression “representatives” shall be deemed to include all delegates, deputy delegates, advisers, technical experts and secretaries of delegations. ARTICLE V OFFICIALS Section 17.- The Secretary-General will specify the categories of officials to which the provisions of this Article and Article VII shall apply. He shall submit these categories to the General Assembly. Thereafter these categories shall be communicated to the Government of all Members. The names of the officials included in these categories shall from time to time be made known to the Government of Members. Section 18.- Official of the United Nations shall:- (a) be immune from legal process in respect of words spoken or written and all acts performed by them in their offical capacity; (b) be exempt from taxation on the salaries and emoluments paid to them by the United Nations; (c) be immune from national service obligations; (d) be immune, together with their spouses and relatives dependent on them, from immigration restrictions and alien registration; (e) be accorded the same privileges in respect of exchange facilities as are accorded to the officials of comparable ranks forming part of diplomatic missions to the Government concerned; (f) be given together with their spouses and relatives dependent on them, the same repatriation facilities in time of international crisis as diplomatic envoys; (g) have the right to import free of duty their furniture and effects at the time of first taking up their post in the country in question. Section 19.- In addition to the immunities and privileges specified in Section 18, the Secretary-General and all Assistant Secretaries-General shall be accorded in respect of themselves their spouses and minor children, the privileges and immunities, exemptions and facilities accorded to diplomatic envoys, in accordance with international law. Section 20.-Privileges and immunities are granted to officials in the interests of the United Nations and not for the personal benefit of the individuals themselves. The Secretary-General shall have the right and duty to waive the immunity of any official in case where, in his opinion, the immunity would impede the course of justice and can be waived without prejudice to the interests of the United Nations. In the case of the Secretary-General, the Council shall have the right to waive immunity. Section 21.- The United Nations shall cooperate at all times with the appropriate authorities of Members to facilitate the proper administration of justice, seccure the observance of police regulations and prevent the occurrence of any abuse in connection with the privileges, immunities and facilities mentioned in this Article. ARTICLE VI EXPERTS ON MISSION FOR THE UNITED NATIONS Section 22.- Experts (other than officials coming within the scope of Article V) performing missions for the United Nations shall be accorded such privileges and immunities as are necessary for the independent exercise of their functions during the period of their mission, including the time spent on journeys in connection with their mission. In particular they shall be accorded:- (a) immunity from personal arrest or detention and from seizure of their personal baggage; (b) in respect of words spoken or written and acts done by them in the course of the performance of their mission immunity from legal process of every kind. This immunity from legal process shall continue to be accorded notwithstanding this the persons concerned are no longer employed on mission for the United Nations; (c) inviolability for all papers and documents; (d) for the purpose of their communications with the United Nations, the right to use codes and to receive papers or correspondence by courier or in sealed bags; (e) the same facilities in respect of currency or exchange restrictions as are accorded to representatives of foreign government on temporary official mission; (f) the same immuniteies and facilities in respect of their personal baggage as accorded to diplomatic envoys. Section 23.- Privileges and immunities are granted to experts in the interests of the United Nations and not for the personal benfit of the individuals themselves. The Secretary-General shall have the right and the duty to waive the immunity of any expert in any case where, in his opinion, the immunity would impede the course of justice and it can be waived without prejudice to the interests of the United Nations. ARTICLE VII UNITED NATIONS LAISSEZ - PASSER Section 24.- The United Nations may issue United Nations laissez-passer to its officials. These laissez-passer shall be recognized and accepted as valid travel documents by the authorites of Members, taking into account the provisions of Section 25. Section 25.-Application for visas (where required) from the holders of United Nations laissez-passer, when accompanied by a certificte that they are travelling on the business of the United Nations, shall be dealt with as speedily as possible. In addition, such person shall be granted facilities for speedy travel. Section 26.- Similar facilities to those specified in Section 25 shall be acccorded to experts and other persons who, though not the holder of the United Nations laissez-passer, have a certificate that they are travelling on the business of the United Nations. Section 27.- The Secreary-General, Assistant Secretaries-General and Directors travelling on the united Nations laissez-passer on the business of the United Nations shall be granted the same facilities as are accorded to diplomatic envoys. Section 28.- The provisions of this article may be applied to the comparable officals of specialized agencies if the agreements for relationship made under Article 63 of the Charter so provide. ARTICLE VIII SETTLEMENT OF DISPUTES Section 29.- The United Nations shall make provisions for appropriate modes of settlement of;- (a) disputes arising out of contracts or other disputes of a private law character to which the United Nations is a party; (b) disputes involving any official of the United Nations who by reason of his offical position enjoys immunity, if immunity has not been waived by the Secretary-General. Sections 30.- All differences arising out of the interpretation or application of the present Convention shall be referred to the international Court of Justice, unless in any case it is agreed by the parties to have recourse to another mode of settlement. If a difference arises between the United Nations on the one hand and a Member on other hand, a request shall be made for an advisory opinion on any legal question involved in accordance with Article 96 of the Charter and Article 65 of the Statute of the Court. The opinion given by the Court shall be accepted as decisive by the parties.